Stock Scorecard



Stock Summary for Teleflex Incorporated (TFX) - $119.12 as of 12/3/2025 8:54:01 PM EST

Total Score

8 out of 30

Safety Score

44 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TFX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TFX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TFX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for TFX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for TFX (44 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for TFX

Teleflex Incorporated Announces Upcoming Conference Call and Virtual Meeting for Q3 Financial Results and Vascular Intervention Business Review - Quiver Quantitative 10/16/2025 8:43:00 PM
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details 10/16/2025 8:33:00 PM
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular ... - Bluefield Daily Telegraph 10/16/2025 8:33:00 PM
Teleflex Announces Third Quarter 2025 Earnings Conference - GlobeNewswire 10/16/2025 8:30:00 PM
Price-Driven Insight from (TFX) for Rule-Based Strategy - news.stocktradersdaily.com 10/16/2025 6:32:00 AM
Teleflex Q2 2025 slides: modest growth, raised guidance, strategic progress By Investing.com - Investing.com Nigeria 10/15/2025 8:22:00 PM
Earnings call transcript: Teleflex Q2 2025 sees revenue growth, stock stable - Investing.com Nigeria 10/15/2025 7:57:00 PM
Teleflex Q2 2025 slides: modest growth, raised guidance, strategic progress - Investing.com India 10/15/2025 10:39:00 AM
Teleflex Q2 2025 slides: modest growth, raised guidance, strategic progress By Investing.com - Investing.com South Africa 10/15/2025 12:48:00 AM
Earnings call transcript: Teleflex Q2 2025 sees revenue growth, stock stable - Investing.com 10/15/2025 12:08:00 AM

Financial Details for TFX

Company Overview

Ticker TFX
Company Name Teleflex Incorporated
Country USA
Description Teleflex Incorporated (TFX), headquartered in Wayne, Pennsylvania, is a prominent global provider of innovative medical devices, specializing in critical care and surgical applications. The company boasts an extensive portfolio of specialty products aimed at enhancing patient safety and treatment outcomes across diverse medical procedures. Teleflex is dedicated to advancing healthcare through its commitment to innovation and high-quality standards, establishing itself as a trusted partner for clinicians and patients worldwide. With a strong emphasis on improving patient care, Teleflex continues to drive advancements in medical technology, positioning itself as a leader in the healthcare industry.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 9/30/2025
Next Earnings Date 2/19/2026

Stock Price History

Last Day Price 119.12
Price 4 Years Ago 319.26
Last Day Price Updated 12/3/2025 8:54:01 PM EST
Last Day Volume 737,829
Average Daily Volume 615,955
52-Week High 187.52
52-Week Low 102.26
Last Price to 52 Week Low 16.49%

Valuation Measures

Trailing PE N/A
Industry PE 389.65
Sector PE 88.06
5-Year Average PE 17.03
Free Cash Flow Ratio 14.87
Industry Free Cash Flow Ratio 42.91
Sector Free Cash Flow Ratio 28.78
Current Ratio Most Recent Quarter 2.57
Total Cash Per Share 8.01
Book Value Per Share Most Recent Quarter 86.48
Price to Book Ratio 1.32
Industry Price to Book Ratio 3.52
Sector Price to Book Ratio 33.12
Price to Sales Ratio Twelve Trailing Months 1.59
Industry Price to Sales Ratio Twelve Trailing Months 46.33
Sector Price to Sales Ratio Twelve Trailing Months 15.97
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 44,194,400
Market Capitalization 5,264,436,928
Institutional Ownership 108.27%

Dividends

Ex-Dividend Date 11/14/2025
Previous Dividend Amount 0.3400
Current Dividend Amount 0.3400
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 1.36
Trailing Annual Dividend Yield 1.19%
Forward Annual Dividend Rate 1.36
Forward Annual Dividend Yield 1.19%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 0.84%
5-Year Average Dividend Yield 0.70%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 7.48%
Dividend Payout Ratio -18.97%

Income Statement

Quarterly Earnings Growth YOY 64.10%
Annual Earnings Growth -80.45%
Reported EPS 12 Trailing Months -7.17
Reported EPS Past Year 10.31
Reported EPS Prior Year 14.01
Net Income Twelve Trailing Months -327,966,000
Net Income Past Year 69,675,000
Net Income Prior Year 356,328,000
Quarterly Revenue Growth YOY 19.40%
5-Year Revenue Growth 3.26%
Operating Margin Twelve Trailing Months 12.40%

Balance Sheet

Total Cash Most Recent Quarter 353,997,000
Total Cash Past Year 290,188,000
Total Cash Prior Year 222,848,000
Net Cash Position Most Recent Quarter -2,217,507,000
Net Cash Position Past Year -1,265,683,000
Long Term Debt Past Year 1,555,871,000
Long Term Debt Prior Year 1,727,572,000
Total Debt Most Recent Quarter 2,571,504,000
Equity to Debt Ratio Past Year 0.73
Equity to Debt Ratio Most Recent Quarter 0.60
Total Stockholder Equity Past Year 4,278,140,000
Total Stockholder Equity Prior Year 4,440,988,000
Total Stockholder Equity Most Recent Quarter 3,821,863,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 264,333,000
Free Cash Flow Per Share Twelve Trailing Months 5.98
Free Cash Flow Past Year 509,305,000
Free Cash Flow Prior Year 419,196,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -3.77
MACD Signal -4.32
20-Day Bollinger Lower Band 105.23
20-Day Bollinger Middle Band 120.58
20-Day Bollinger Upper Band 135.93
Beta 0.95
RSI 48.80
50-Day SMA 135.20
150-Day SMA 194.75
200-Day SMA 210.71

System

Modified 12/2/2025 10:12:07 AM EST